EPH19 Long Term Epidemiological Impact of Adjuvant Atezolizumab in Preventing the Recurrence of Early PDL1 High Non-Small Cell Lung Cancer in Europe
Abstract
Authors
P Napalkov A Tomar A Dubey N Jovanoski K Schwarz E Heaton M Arnold